Sitagliptin Phosphate and Dapagliflozin 

Sitagliptin Phosphate and Dapagliflozin 
ST- Gliptin Dapa is a combination of two different medications used to treat type 2 diabetes.
Sitagliptin phosphate is a medication that works by inhibiting an enzyme called dipeptidyl peptidase-4 (DPP-4), which increases the amount of insulin released by the pancreas and reduces the amount of glucose produced by the liver. It is typically taken once a day with or without food.
Dapagliflozin is a medication that works by blocking a protein called sodium-glucose cotransporter 2 (SGLT2), which reduces the amount of glucose reabsorbed by the kidneys and increases glucose excretion in the urine. It is typically taken once a day with or without food.
ST- Gliptin Dapa will help to control blood sugar levels in patients with type 2 diabetes. The dosage and frequency of ST- Gliptin Dapa will depend on the individual patient's condition and their response to treatment.
Common side effects of ST- Gliptin Dapa may include headache, sore throat, and stomach pain.
For further information please contact:
info@sterispharma.com